1. Nazar, A., J. Anush, R. Mathew and P.K. Prabhakar, 2023. Clinical utility of small, dense LDL as an atherogenic risk marker. Biointerface Res. Appl. Chem., Vol. 13. 10.33263/BRIAC132.199.
   CrossRef  |  Direct Link  |  
2. Prabhawathi, V., P.M. Sivakumar, P.K. Prabhakar, S. Cetinel and R. Neelakandan, 2022. Molecular insights on the therapeutic effect of selected flavonoids on diabetic neuropathy. Mini-Rev. Med. Chem., 22: 1828-1846.
   CrossRef  |  Direct Link  |  
3. Mishra, Y., H.I.M. Amin, V. Mishra, M. Vyas and P.K. Prabhakar et al., 2022. Application of nanotechnology to herbal antioxidants as improved phytomedicine: An expanding horizon. Biomed. Pharmacother., Vol. 153. 10.1016/J.BIOPHA.2022.113413.
   CrossRef  |  Direct Link  |  
4. Dubey, R., P.K. Prabhakar and J. Gupta, 2022. Identification of structurally similar phytochemicals to quercetin with high sirt1 binding affinity and improving diabetic wound healing by using in silico approaches. Biointerface Res. Appl. Chem., 12: 7621-7632.
   CrossRef  |  Direct Link  |  
5. Dubey, R., P.K. Prabhakar and J. Gupta, 2022. Epigenetics: Key to improve delayed wound healing in type 2 diabetes. Mol. Cell. Biochem., 477: 371-383.
   CrossRef  |  Direct Link  |  
6. Anush, N., A. Jasmin, P.K. Prabhakar, R. Mathew and C.P. Bineesh, 2022. Predictors of severe COVID-19 Outcome: A meta-analysis of common laboratory biomarkers. ECS Trans., 107: 8531-8550.
   CrossRef  |  Direct Link  |  
7. Sivakumar, P.M., V. Prabhawathi, A. Zarrabi, S. Akthar and P.K. Prabhakar, 2021. Current trends in the therapeutic strategies for diabetes management. Curr. Med. Chem., 28: 4616-4637.
   CrossRef  |  Direct Link  |  
8. Sivakumar, P.M., B. Premkumar, V. Prabhawathi and P.K. Prabhakar, 2021. Role of GLP-1 analogs in the management of diabetes and its secondary complication. Mini-Rev. Med. Chem., 21: 3166-3182.
   CrossRef  |  Direct Link  |  
9. Prabhakar, P.K., 2021. Synergistic interaction of cinnamic acid derivatives with commercial oral antidiabetic drugs. Metabolism, Vol. 116. 10.1016/J.METABOL.2020.154600.
   CrossRef  |  Direct Link  |  
10. Manimaran, V., P.M. Sivakumar, J. Narayanan, S. Parthasarathi and P.K. Prabhakar, 2021. Nanoemulsions: A better approach for antidiabetic drug delivery. Curr. Diabetes Rev., 17: 486-495.
    CrossRef  |  Direct Link  |  
11. Prabhakar, P.K., K. Singh, D. Kabra and J. Gupta, 2020. Natural SIRT1 modifiers as promising therapeutic agents for improving diabetic wound healing. Phytomedicine, Vol. 76. 10.1016/j.phymed.2020.153252.
    CrossRef  |  Direct Link  |  
12. Prabhakar, P.K. and J. Lakhanpal, 2020. Recent advances in the nucleic acid-based diagnostic tool for coronavirus. Mol. Biol. Rep., 47: 9033-9041.
    CrossRef  |  Direct Link  |  
13. P.K. Prabhakar, 2020. Bacterial siderophores and their potential applications: A review. Curr. Mol. Pharmacol., 13: 295-305.
    CrossRef  |  Direct Link  |  
14. Banerjee, M., R. Khursheed, A.K. Yadav, S.K. Singh and M. Gulati et al., 2020. A systematic review on synthetic drugs and phytopharmaceuticals used to manage diabetes. Curr. Diabetes Rev., 16: 340-356.
    CrossRef  |  Direct Link  |  
15. Sharma, S., J. Gupta, P.K. Prabhakar, P. Gupta, P. Solanki and A. Rajput, 2019. Phytochemical repurposing of natural molecule: Sabinene for identification of novel therapeutic benefits using in silico and in vitro approaches. Assay Drug Dev. Technol., 17: 339-351.
    CrossRef  |  Direct Link  |  
16. Sharma, A., S. Devi, K. Singh and P.K. Prabhakar, 2018. Correlation of body mass index with thyroid-stimulating hormones in thyroid patient. Asian J. Pharm. Clin. Res., 11: 65-68.
    CrossRef  |  Direct Link  |  
17. Jayaswal, R.P., M. Vijaysimha and P.K. Prabhakar, 2018. Gut microbiota and diabetes mellitus-an interlinkage. Asian J. Pharmaceut. Clin. Res., 11: 13-16.
    Direct Link  |  
18. Neupane, N., M. Kaur and P.K. Prabhakar, 2017. Treatment of Hashimoto's thyroiditis with herbal medication. Int. J. Green Pharm., 11: S343-S347.
19. Nankar, R., P.K. Prabhakar and M. Doble, 2017. Hybrid drug combination: Combination of ferulic acid and metformin as anti-diabetic therapy. Phytomedicine, 37: 10-13.
    CrossRef  |  Direct Link  |  
20. Jayaswal, R.P. and P.K. Prabhakar, 2017. Probiotics-a new diabetes management tool. Int. J. Green Pharm., 11: S395-S400.
21. Jamatia, A., D. Roy, R. Shil and P.K. Prabhakar, 2017. Bacteriological profile and antimicrobial resistance patterns isolates in pus samples at agartala government medical college. Asian J. Pharm. Clin. Res., 10: 1-3.
22. Prabhakar, P.K., 2016. Pathophysiology of secondary complications of diabetes mellitus. Asian J. Pharm. Clin. Res., 9: 32-36.
23. Prabhakar, P.K., 2016. Animal Models in Type 2 Diabetes Research. In: Recent Progress in Medicinal Plants, Volume 43: Phytotherapeutics II, Pathak, M. and J.N. Govil (Eds.). Studium Press LLC, USA., ISBN-10: 1-62699-080-8, pp: 525-550.
24. Kirti, P.K.P., 2016. Human papilloma virus associated cervical cancer: A review. Asian J. Pharm. Clin. Res., 9: 14-17.
25. Kaur, H., M.H. Amini, P.K. Prabhakar, A. Singh and A. Suttee, 2016. Phytochemical screening and antimicrobial activity of Caesalpinia sappan L. leaves. Int. J. Pharm. Phytochem. Res., 8: 1064-1069.
26. Kaur, G., P.K. Prabhakar, U.R. Lal and A. Suttee, 2016. Phytochemical and biological analysis of Tinospora cordifolia. Int. J. Toxicol. Pharmacol. Res., 8: 297-305.
27. Prabhakar, P.K., 2015. Nutraceuticals as Therapeutic Agent: A Novel Approach. In: Recent Progress in Medicinal Plants, Volume 42: Nutraceuticals and Functional Foods, Pathak, M. and J.N. Govil (Eds.). Chapter 8, Studium Press, USA., ISBN-10: 1-62699-079-4, pp: 141-156.
28. Popli, P. and P.K. Prabhakar, 2015. Significance of tacrolimus monitoring to optimize immunosuppressive therapy. Int. J. Pharma Bio Sci., 6: 191-198.
29. Chakarborty, P.S., H. Sapkota and P.K. Prabhakar, 2015. Synergistic interaction of cannabis and garlic with commercial antibiotics. Int. J. Pharmacogn. Phytochem. Res., 7: 193-196.
    Direct Link  |  
30. Prabhakar, P.K., A. Kumar and M. Doble, 2014. Combination therapy: A new strategy to manage diabetes and its complications. Phytomed., 21: 123-130.
    CrossRef  |  PubMed  |  Direct Link  |  
31. Maaji, S.U. and P.K. Prabhakar, 2014. Hypovitaminosis D in type-2 diabetes mellitus patients: Variation with age, sex and season. Indian J. Appl. Res., 4: 422-425.
32. Devi, A.R., J.A. Chelvane, P.K. Prabhakar, P.P. Priya, M. Doble and B.S. Murty, 2014. Generation of drugs coated iron nanoparticles through high energy ball milling. J. Appl. Phys., Vol. 115. 10.1063/1.4868681.
    CrossRef  |  Direct Link  |  
33. Devi, A.R., J.A. Chelvane, P.K. Prabhakar, B. Venkateswarlu, M. Doble and B.S. Murty, 2014. Influence of surfactant variation on effective anisotropy and magnetic properties of mechanically milled magnetite nanoparticles and their biocompatibility. IEEE Trans. Magn., 50: 1-4.
    CrossRef  |  Direct Link  |  
34. Prabhakar, P.K., R. Prasad, S. Ali and M. Doble, 2013. Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine, 20: 488-494.
    CrossRef  |  PubMed  |  Direct Link  |  
35. Sivakumar, P.M., P.K. Prabhakar and M. Doble, 2011. Synthesis, antioxidant evaluation, and quantitative structure-activity relationship studies of chalcones. Med. Chem. Res., 20: 482-492.
    CrossRef  |  Direct Link  |  
36. Pranav, K.P., V. Swetha, P. John and D. Mukesh, 2011. Biocompatibility studies of functionalized CoFe2O4 magnetic nanoparticles. Curr. Nanosci., 7: 371-376.
    CrossRef  |  Direct Link  |  
37. Prabhakar, P.K., S. Raj, P.R. Anuradha, S.N. Sawant and M. Doble, 2011. Biocompatibility studies on polyaniline and polyaniline-silver nanoparticle coated polyurethane composite. Colloids Surf. B Biointerfaces, 86: 146-153.
    CrossRef  |  PubMed  |  Direct Link  |  
38. Prabhakar, P.K. and M. Doble, 2011. Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin. J. Integr. Med., 17: 563-574.
    PubMed  |  Direct Link  |  
39. Prabhakar, P.K. and M. Doble, 2011. Interaction of phytochemicals with hypoglycemic drugs on glucose uptake in L6 myotubes. Phytomed., 18: 285-291.
    CrossRef  |  PubMed  |  Direct Link  |  
40. Prabhakar, P.K. and M. Doble, 2011. Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes. J. Agric. Food Chem., 59: 9835-9844.
    CrossRef  |  PubMed  |  Direct Link  |  
41. Prabhakar, P.K. and M. Doble, 2011. Effect of natural products on commercial oral antidiabetic drugs in enhancing 2-deoxyglucose uptake by 3T3-L1 adipocytes. Ther. Adv. Endocrinol. Metab., 2: 103-114.
    CrossRef  |  PubMed  |  Direct Link  |  
42. Prabhakar, P.K. and M. Doble, 2009. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomed., 16: 1119-1126.
    CrossRef  |  PubMed  |  Direct Link  |  
43. Prabhakar, P.K. and M. Doble, 2008. Mechanism of Action of Medicinal Plants Towards Diabetes Mellitus-A Review. In: Recent Progress in Medicinal Plants, Volume 22: Phytopharmacology and Therapeutic Values IV, Govil, J.N., V.K. Singh and R. Bhardwaj (Eds.). Studium Press LLC, USA., ISBN-10: 1-933699-12-4, pp: 181-204.
44. Prabhakar, P.K. and M. Doble, 2008. A target based therapeutic approach towards diabetes mellitus using medicinal plants. Curr. Diabetes Rev., 4: 291-308.
    Direct Link  |